BEIJING, May 19 (Xinhua) -- A study by Chinese researchers has found that the COVID-19 booster vaccination can markedly reduce the immune escape of the Omicron variant, underscoring the necessity for the eligible population to get a third booster jab to combat the pandemic. The researchers fro...
with the booster to be administered at least two months following their primary three-dose vaccination series with the original Pfizer-BioNTech COVID-19 jab. It is also authorized as the third dose for children of this age group who have yet to receive the final shot for their primary...
They give excellent protection against the originalCOVID-19virus and the Kent variant. They are also likely to prevent many - but probably not all - cases of severe disease caused by the South African and Brazilian variants of the virus, which have mutations that help them to...
and our data clearly shows that this additional antigenic exposure produces an extra boost to the overall virus-killing antibody response that is more effective against variants of concern. Our results support the UK Government's plan to provide a booster jab in the autumn as an effective strategy...
Covid-19 booster vaccine jabs for millions of people in England will begin to be offered this week, the NHS has announced. The vaccine will be available to care home residents, people who are 75 and over, and the immunosuppressed aged 12 and over. ...
Switzerland on Tuesday authorised booster shots of COVID-19 vaccines for the over-65s, as it urged those with no protection at all to get immunised. Ad The Swissmedicregulatory authoritysaid the booster would be one shot of the Pfizer-BioNTech vaccine, or a half-dose of Moderna. ...
Johnson & Johnson's COVID-19 vaccine has been a minor player in the US vaccination drive so far, but the company hopes it can have a bigger role as a booster shot. The drugmaker has filed for approval of a second dose of its one-shot Ad26.COV2.S vaccine
COVID-19 vaccinesSEASONSMEDICAL protocolsSEASONAL influenzaMIDDLE ageOLD ageThe article reports on the announcement by United Kingdom's (UK) Department of Health and Social Care (DHSC) that a COVID-19 booster vaccine and flu jabs will be offered to adult people ...
The findings of the research, informed by data from Brazil and Scotland, suggest that booster programmes are, therefore, needed to help maintain protection from severe disease in those that have received the initial doses of the jab. During the research period, scientis...
Chen's group and the researchers from the Jiangsu Provincial Center for Disease Control and Prevention conducted a randomized, open-label, controlled trial to evaluate the vaccine's safety and immunogenicity as a booster jab in 420 Chinese adults who had previously received two doses of inactivated...